GL1X · GenesisL1 explorer

MolNFT v1 · #91603 · protein

Kinetic stabilization of transthyretin through covalent modification of K15 by 4-bromo-3-(5-(3,5-dichloro-4-hydroxyphenyl)-1,3,4- oxadiazol-2-yl)-benzenesulfonamide

4FI8: “Kinetic stabilization of transthyretin through covalent modification of K15 by…”. X-ray diffraction, 1 ligand (0UC), 2 pockets (best druggability 0.33). MolNFT v1 #91603 on GenesisL1: 3D structure, binding sites and pockets in GL1X.

PDB
4FI8
Type
protein
Length
231 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Transthyretin
UniProt
P02766
Ligands
0UC
Pockets
2 · best druggability 0.33

Structure

x-ray diffraction · 2 distinct chains · 6% helix, 53% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ATransthyretinprotein1166% helix, 53% strandP02766
BTransthyretinprotein1157% helix, 53% strandP02766

Ligands and binding sites

  • 0UC · 4-bromo-3-[5-(3,5-dichloro-4-hydroxyphenyl)-1,3,4-oxadiazol-2-yl]benzenesulfonyl fluoride · ligand · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
1540.330.7814empty
2670.310.7514empty

Interfaces

1 interface between chains.

  • A–B · 927 Ų buried · 19 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 2 covalent (covalent ligand).

Compared structures

  • 4FI8 · Kinetic Stabilization of transthyretin through covalent modification of K15 by… · the same entry in another collection · chain B against B, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.